These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34998409)

  • 1. VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy.
    Cheng C; Weiss L; Leinonen H; Shmara A; Yin HZ; Ton T; Do A; Lee J; Ta L; Mohanty E; Vargas J; Weiss J; Palczewski K; Kimonis V
    J Transl Med; 2022 Jan; 20(1):21. PubMed ID: 34998409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy.
    Weiss L; Jung KM; Nalbandian A; Llewellyn K; Yu H; Ta L; Chang I; Migliore M; Squire E; Ahmed F; Piomelli D; Kimonis V
    Hum Mol Genet; 2021 Feb; 29(24):3945-3953. PubMed ID: 33410456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6.
    Leinonen H; Cheng C; Pitkänen M; Sander CL; Zhang J; Saeid S; Turunen T; Shmara A; Weiss L; Ta L; Ton T; Koskelainen A; Vargas JD; Kimonis V; Palczewski K
    J Pharmacol Exp Ther; 2021 Jul; 378(1):31-41. PubMed ID: 33931547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
    Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
    Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
    Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
    PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.
    Llewellyn KJ; Nalbandian A; Jung KM; Nguyen C; Avanesian A; Mozaffar T; Piomelli D; Kimonis VE
    Hum Mol Genet; 2014 Mar; 23(5):1333-44. PubMed ID: 24158850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.
    Nalbandian A; Llewellyn KJ; Badadani M; Yin HZ; Nguyen C; Katheria V; Watts G; Mukherjee J; Vesa J; Caiozzo V; Mozaffar T; Weiss JH; Kimonis VE
    Muscle Nerve; 2013 Feb; 47(2):260-70. PubMed ID: 23169451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease.
    Nalbandian A; Nguyen C; Katheria V; Llewellyn KJ; Badadani M; Caiozzo V; Kimonis VE
    PLoS One; 2013; 8(10):e76187. PubMed ID: 24130765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
    Weihl CC; Miller SE; Hanson PI; Pestronk A
    Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.
    Nalbandian A; Llewellyn KJ; Nguyen C; Yazdi PG; Kimonis VE
    PLoS One; 2015; 10(4):e0122888. PubMed ID: 25884947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models.
    Phan JM; Creekmore BC; Nguyen AT; Bershadskaya DD; Darwich NF; Mann CN; Lee EB
    J Clin Invest; 2024 May; 134(14):. PubMed ID: 38787785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
    Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent-onset multisystem proteinopathy due to a novel VCP variant.
    Soontrapa P; Seven NA; Liewluck T; Cui G; Mer G; Milone M
    Neuromuscul Disord; 2024 Jan; 34():89-94. PubMed ID: 38159460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report.
    Kobayashi R; Naruse H; Kawakatsu S; Iseki C; Suzuki Y; Koyama S; Morioka D; Ishiura H; Mitsui J; Ohta Y; Tsuji S; Toda T; Otani K
    BMC Neurol; 2022 Nov; 22(1):406. PubMed ID: 36329418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.
    Arhzaouy K; Papadopoulos C; Schulze N; Pittman SK; Meyer H; Weihl CC
    Autophagy; 2019 Jun; 15(6):1082-1099. PubMed ID: 30654731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
    Ritson GP; Custer SK; Freibaum BD; Guinto JB; Geffel D; Moore J; Tang W; Winton MJ; Neumann M; Trojanowski JQ; Lee VM; Forman MS; Taylor JP
    J Neurosci; 2010 Jun; 30(22):7729-39. PubMed ID: 20519548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease.
    Badadani M; Nalbandian A; Watts GD; Vesa J; Kitazawa M; Su H; Tanaja J; Dec E; Wallace DC; Mukherjee J; Caiozzo V; Warman M; Kimonis VE
    PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cure VCP Scientific Conference 2021: Molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1).
    Johnson MA; Klickstein JA; Khanna R; Gou Y; ; Raman M
    Neurobiol Dis; 2022 Jul; 169():105722. PubMed ID: 35405261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo.
    Kustermann M; Manta L; Paone C; Kustermann J; Lausser L; Wiesner C; Eichinger L; Clemen CS; Schröder R; Kestler HA; Sandri M; Rottbauer W; Just S
    Autophagy; 2018; 14(11):1911-1927. PubMed ID: 30010465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.